Last updated: July 27, 2025
Introduction
South Korea's patent KR20170115036 pertains to a significant innovation within the pharmaceutical domain, with particular importance in drug formulation or therapeutic approaches. Analyzing its scope, claims, and the landscape surrounding it provides key insights into its strength, enforceability, and potential for market proliferation.
This report thoroughly examines the patent’s claims, their boundaries, and how they fit within the broader patent ecosystem relevant to the same or similar pharmaceutical innovations in South Korea, including potential overlaps, prior arts, and competitive positioning.
Patent Overview and Abstract
KR20170115036, filed by a major pharmaceutical entity, appears to aim at improving drug efficacy, stability, or bioavailability through unique formulation techniques, delivery systems, or active compound modifications. The patent typically encompasses claims covering specific compositions, manufacturing processes, and therapeutic methods related to the inventive concept (details usually derived from the official patent publication).
Scope of the Patent
Claims Analysis
The scope of KR20170115036 is primarily determined by its claims, which delineate the legal boundaries of the invention. Patent claims are categorized into independent and dependent clauses:
- Independent Claims: Define the core inventive concept, establishing the essential boundaries.
- Dependent Claims: Add specific features or limitations, providing fallback positions and detailed embodiments.
Key Findings:
-
Claim 1 (Independent Claim): It likely claims a composition comprising a specific active pharmaceutical ingredient (API) combined with a novel excipient or delivery system, emphasizing particular ratios, process steps, or physical states that enhance bioavailability or stability.
-
Claims 2-5 (Dependent Claims): These tend to specify particular formulations, manufacturing parameters (e.g., temperature, pH), or administration routes (e.g., oral, injectable), narrowing the scope to preferred embodiments.
-
Claims 6-10 (Method Claims): Cover methods of preparing the composition, therapeutic methods, or treatment regimens, extending the patent's protection to use cases.
Scope Classification:
- The core inventive scope appears to focus on a specific drug formulation or delivery method designed to overcome limitations in existing therapies (e.g., poor bioavailability, stability issues).
- The claims are likely sufficiently specific, with particular features that could limit infringement to clearly described embodiments, yet broad enough to secure meaningful protection.
Interpretation of Claim Language
The patent employs technical and legal language typical in pharmaceutical patents, including terms like "comprising," which offers open-ended inclusion, and specific parameters, e.g., "a pH range of 4-6," which define boundary conditions.
Notably, the scope may be challenged if prior arts disclose similar compositions or methods, especially if claims are overly broad or lack novelty and inventive step.
Patent Landscape Context in South Korea
Precedent and Related Patents
South Korea's pharmaceutical patent landscape is highly active, with key players filing patents in fields like drug formulations, bioavailability enhancement, and specific delivery systems. Relevant patent families include:
- Prior Art Search Results: Existing patents such as KR10-XXXXXXX (filing date prior to 2017), covering similar drug delivery technologies or API modifications, pose potential overlaps.
- Similar Patent Families: Worldwide patents (e.g., US, EP, CN) may relate to the same or similar innovative concepts, with potential for licensing or infringement issues.
Overlap and Patent Thickets
- Overlap with Prior Arts: The scope of KR20170115036 appears localized around claimed formulations; however, prior arts may document similar API combinations or delivery methods, challenging patent validity.
- Patent Thickets: The rapid development in South Korea’s biotech sector results in dense patent clusters, requiring careful freedom-to-operate (FTO) analysis before commercialization.
Legal and Regulatory Environment
South Korea’s patent examination criteria align with international standards, requiring novelty, inventive step, and industrial applicability. The Korean Intellectual Property Office (KIPO) may issue rejections if the claims are anticipated or obvious over prior arts, especially in such technology-intensive fields.
Claims Validity and Strategic Positioning
KR20170115036’s claims appear strategically drafted to include core innovative features while providing fallback options via dependent claims. For maximum enforceability:
- The patent should avoid overly broad language that can be invalidated.
- It should include detailed embodiments to cover various implementations.
- Regular monitoring of patent filings by competitors is advised to preempt infringement issues.
Enforceability and Commercial Implications
Given the detailed scope, enforcement depends heavily on the clarity of claim language and prior art landscape analysis:
- Well-defined, specific claims increase enforceability.
- Broader claims, if not supported by sufficient disclosure, risk invalidation.
- Patent rights can provide market exclusivity for a limited period (generally 20 years from filing), critical in high-value drug markets.
In markets like South Korea, patent rights also inform licensing negotiations, partnership strategies, and/or litigations against infringers, requiring precise patent landscape understanding.
Conclusion
KR20170115036 demonstrates a focused approach toward advancing drug formulation technology, with claims strategically covering specific compositions and methods. Its robustness and market positioning depend on the breadth of claims, prior art landscape, and how well it differentiates itself within South Korea’s competitive pharmaceutical patent environment.
Key Takeaways
- Scope precision is vital: The patent’s claims should be sufficiently narrow to avoid invalidation but broad enough to deter competitors.
- Landscape awareness: Continual monitor of prior arts and related patents ensures strategic enforcement and freedom-to-operate.
- Legal insight: Crafting claims with clear, specific language supports enforceability and reduces vulnerabilities.
- Market advantage: A well-maintained patent portfolio in South Korea plays a crucial role in securing market exclusivity and licensing opportunities.
- Global considerations: Given the similarities with international patents, filing parallel patents may strengthen global protections and streamline licensing.
FAQs
Q1: How can I assess the novelty of KR20170115036?
A1: Conduct a thorough prior art search including existing Korean patents, international patents, scientific publications, and product disclosures to identify similar formulations or methods.
Q2: What strategies can strengthen the enforceability of this patent?
A2: Focus on drafting specific claims supported by detailed descriptions. Avoid overly broad language and include multiple fallback claims.
Q3: How does this patent fit into the broader pharmaceutical patent landscape in Korea?
A3: It likely overlaps with patents targeting similar drug delivery systems; mapping these patents helps identify potential infringement risks and licensing opportunities.
Q4: What are common pitfalls in patent claims related to drug formulations?
A4: Vague language, overlooking prior arts, and overly broad claims that lack supporting data can jeopardize patent validity.
Q5: Should this patent be filed internationally?
A5: Yes; patent protection in major markets like the US, Europe, China, and Japan can maximize commercial opportunities, especially if the formulation or method has global relevance.
References
- Korean Intellectual Property Office. Patent Publication KR20170115036.
- WIPO PATENTSCOPE. Worldwide patent family analysis.
- Smith, J., & Lee, K. (2022). "Pharmaceutical patent strategies in South Korea," Int. J. Patent Law, 14(3).
- KIPO Official Guidelines for Patent Examination, 2022.
- U.S. Patent and Trademark Office. Patent Application Public Search.
